Contact hours available until 10/31/2021. Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Authors Conflict of Interest Disclosure: The author(s), editor, editorial board, content reviewers, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Information: This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN).
Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nurses, Provider Number CEP 5387.
This article was reviewed and formatted for contact hour credit by Michelle Boyd, MSN, RN, AMSN Education Director.
Learning Outcome: After completing this educational activity, the learner will be able to describe how advances in genetics and genomics have influenced the development of many emerging therapies for bacterial infections.
Learning Engagement Activity: 1. The United Nations General Assembly defined antimicrobial resistance as not only the greatest, but also "the most urgent global risk" as per the CDC. For further study about AMR, reference this CDC website: Centers for Disease Control and Prevention (CDC). (2018a). Antibiotic/Antimicrobial resistance (AR/AMR): United Nations (UN) General Assembly. Retrieved from https://www.cdc.gov/drugresist...
2. Discuss the importance of educating patients and families regarding the safety of vaccines in general and the benefit of vaccines in managing AMR, specifically.